InvestorsHub Logo
icon url

BooDog

08/26/20 6:51 AM

#320640 RE: To infinity and beyond! #320639

Such awesome growth potential for Brilacidin!

Seems we're waiting on protocols and FDA meetings.

Seems we're waiting on peer review and grants.


Oh, I'll go ahead and say it...


SEPTEMBER TO BE THE MONTH TO REMEMBER!!!

GET READY TO BREAK OUT THE RALLY MONKEY!!!
icon url

roiresearch

08/26/20 7:05 AM

#320642 RE: To infinity and beyond! #320639

Its the ic50 value to show the lowest effective dosing.

From the pr
Brilacidin has now exhibited robust in vitro anti-SARS-CoV-2 efficacy at low concentrations, well below already established clinically-achievable concentrations based on pharmacokinetics observed in the Company’s Phase 2b clinical trial of Brilacidin in Acute Bacterial Skin and Skin Structure Infections.